Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons

Clinical Infectious Diseases

Volumn 32, Issue 8, 2001, Pages 1215-1220

  Hajjeh, R A ^a   Pappas, P G ^b   Henderson, H ^c   Lancaster, D ^d   Bamberger, D M ^e   Skahan, K J ^f   Phelan, M A ^a   Cloud, G ^b   Holloway, M ^b   Kauffman, C A ^g   Wheat, L J ^h  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TRIAZOLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; HERPES; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CASE-CONTROL STUDIES; FEMALE; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0035870986     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319756     Document Type: Article

References (20)

1. Disseminated histoplasmosis in persons infected with human immunodeficiency virus
2. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: Incidence, risk factors, and pathophysiology
3. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
4. Revision of the CDC surveillance case definition for the acquired immunodeficiency syndrome
5. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
6. Disseminated histoplasmosis in patients infected with human immunodeficiency virus
7. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome
8. Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-96
9. Cryptococcosis surveillance: Population-based trends, Atlanta and Houston, 1993-98
10. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
11. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced HIV infection
12. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS
13. Itraconazole therapy of histoplasmosis in patients with the acquired immunodeficiency syndrome
14. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome
15. Fluconazole treatment for histoplasmosis in AIDS: Prospective multicenter noncomparative trial
16. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting
17. The disease spectrum of histoplasmosis
18. Predictors of severity in histoplasmosis in AIDS
19. The cost-effectiveness of preventing AIDS-related opportunistic infections
20. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?